A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors

Clinical trial NCT07015697 · RECRUITING

Trial details

NCT number: NCT07015697
Sponsor: Daiichi Sankyo
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent or Metastatic Solid Tumors

Start date: 2025-07-17
Primary completion: 2028-12-31
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.